📢A big thanks to our colleagues from Pau for welcoming our French sales team on their #fillandfinish #sterilemanufacturing site! We had such a great time during working sessions to share #cdmoexpertise and during 🏉⚽ sport activities 🏀🏆 to reinforce the #teamspirit with RUGBY PARK 64. Happy to have new members in the team✨#onboarding, and best wishes to the ones evolving to new adventures!
Eurofins CDMO
Fabrication de produits pharmaceutiques
Fontenilles, Haute-Garonne 8 056 abonnés
Your CDMO expert for drug development
À propos
Eurofins CDMO is a leading global Contract Development and Manufacturing Organization (CDMO) that provides clients with APIs / Drug Substance and Drug Product development for biologicals and small molecules. Science is our fondation and allows us to support small and major biopharmaceutical companies. Our sustainable and flexible methods help them achieve their pre-clinical and clinical milestones on time. We are experts in breakthrough technologies for API development, highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs, pediatric dosage forms, etc.) Involved in the earliest steps, our highly-qualified project management team will propose a complete drug development strategy in compliance with regulations. Frequent communication through one single point of contact, our team's flexibility, troubleshooting mindset, customized solutions will help speed up the drug development process. Operating under strict quality procedures, Eurofins CDMO is accredited through the FDA, EMA, ANSM, ANSES, FAMHP, PMDA, and Health Canada. Our goal is to build a sustainable partnership with our customers to support their drug development pathway. Our service offerings include: - Drug Substance/API development - Solid State Research & Development - Pre-Formulation, Formulation Development - Analytical Development - GMP Manufacturing - Clinical packaging and logistics - Project management - CMC RA Choose Eurofins CDMO to help you: - Move rapidly through the drug development value chain (API/DS and DP) - Perform complex formulation screening and development - Accelerate process development and scale-up under GMP compliance - Achieve clinical & small commercial manufacturing batches (Sterile and Non Sterile) - Provide clinical trial material including packaging and logistics - Ensure regulatory compliance throughout each stage of the development cycle with full CMC-RA support
- Site web
-
http://www.eurofins.com/cdmo/
Lien externe pour Eurofins CDMO
- Secteur
- Fabrication de produits pharmaceutiques
- Taille de l’entreprise
- 201-500 employés
- Siège social
- Fontenilles, Haute-Garonne
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2010
- Domaines
- analytical services, bioanalytical, quality control, in life studies, CDMO, formulation, small molecules, biologics, drug product, R&D, chemistry, microbiology, stability studies, testing, sterile manufacturing, method development, clinical packaging and logistics, USP/DSP, Fill & Finish, Life Cycle Management, API, cell banking et drug development
Lieux
Employés chez Eurofins CDMO
-
Yannick Lussagnet
Responsable informatique chez Amatsigroup
-
Jody Voorspoels
Sr Dir Science & Innovation @ Eurofins CDMO | Pharma Expertise
-
Wouter Mijs
Project Leader at Eurofins Amatsigroup NV
-
Stephen Panaro, Ph.D.
Experienced in Development and Manufacturing of OTC, Pharma, Cosmetics, and Medical Devices
Nouvelles
-
Eurofins CDMO a republié ceci
“While the advent of, and increase in utility of accelerated review programs such as Breakthrough Designations has encouraged development of candidates for severe or rare diseases, they are also subject to strategic challenges, including requirement to think about greater CMC scope, earlier in programs,” says Graham McGowan, Senior Manager of CMC & Regulatory Services at Eurofins CDMO Alphora Inc. Graham recently shared his insights with the American Pharmaceutical Review on the ways in which proactive #CMC Development, from clinical study to commercial stages, can resolve common #drugmanufacturing or filing pitfalls. Read the whitepaper for more from Graham 👉 https://lnkd.in/gTQuCAv4
-
Eurofins CDMO a republié ceci
📣 NEWS ALERT 📣 Eurofins CDMO Alphora Inc. is delighted to share a significant expansion of our Drug Product Analytical Services Laboratory in Mississauga, Canada. The expansion will enable us to offer enhanced support for drug product programs. For further information 👉https://lnkd.in/gUSswqE9 #eurofins #cdmo #pharma #drugdevelopment #analyticalservices #lifesciences #news #expansion
-
Eurofins CDMO a republié ceci
Eurofins CDMO Alphora Inc. is thrilled to announce our most recent publication in Organic Letters, in collaboration with Pfizer. The paper titled, "General and Scalable Synthesis of 2-Aryl and 2-Alkyl Pyrimidines via an Electronically Tuned SNAr Approach" describes an efficient SNAr approach for generating 2-aryl and 2-alkyl pyrimidines without precious metal catalysts and is compatible with aryl, heteroaryl, and alkyl magnesium halides as nucleophiles. Congratulations to the team! #eurofins #cdmo #organicsynthesis #publication #collaboration To access 👉 https://lnkd.in/g2SGAN8E
-
📷 LIVE: Anne-Gaelle Fournial & Hubert LOCHARD were at #DDFSummit in Berlin this week and today is the last day! #eurofins #eurofinscdmo #DDFSummit #drugdelivery #drugformulation
-
📅 SAVE THE DATE ! Meet Eurofins CDMO and Eurofins BioPharma Product Testing (Belgium) teams at booth 59 at Knowledge for Growth in Antwerp on May 15-16! Want to chat about your projects? We've got integrated solutions that can make your life easier! Contact us: https://lnkd.in/gzvqxJJW Event by flanders.bio #eurofinscdmo #eurofins #cdmo #KfG2024
-
📅 SAVE THE DATE ! Stefano Baila and Nicolò Sacchetti, PhD will be attending the #ASGCT2024 Annual Meeting in Baltimore (USA) on May 7-11 with the Eurofins Cell & Gene Therapy team 🧬 Meet them at booth #2253!🤝 Swipe to discover our CDMO and global Eurofins Cell & Gene services⬇️ or click here to contact us 📧 https://lnkd.in/gHduBVsC Event by American Society of Gene & Cell Therapy #eurofins #eurofinscdmo #cdmo #cellgene #biologics
-
#WorldImmunizationWeek Eurofins CDMO is proud to support the necessary collective action and to promote the use of vaccines to protect people of all ages against vaccine-preventable diseases. #Immunization saves millions of lives every year. #eurofinscdmo is ideally suited for the development of your #vaccines, from the formulation to the sterile manufacturing. You want to bring your next vaccine to life? Let's connect and discuss how we can support! https://lnkd.in/d45W7tS #eurofins #cdmo #vaccinedevelopment
-
📷 LIVE: Aurore CHATRON-COLLIET & Luís Raiado are at 𝗦𝘄𝗶𝘀𝘀 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗗𝗮𝘆 in Basel with our Eurofins Optimed Clinical Research colleagues Roman GRIFFET & Thomas DUPONT 😄 Come to meet them at booth #73 ! Event by Swiss Biotech Association #eurofins #eurofinscdmo #swissbiotechday #drugdevelopment